WallStreetZenWallStreetZen

NASDAQ: VVOS
Vivos Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their VVOS stock forecasts and price targets.

Forecast return on equity

Is VVOS forecast to generate an efficient return?
Company
-1,661.36%
Industry
20.3%
Market
31.36%
VVOS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is VVOS forecast to generate an efficient return on assets?
Company
-63.64%
Industry
10.67%
VVOS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

VVOS revenue growth forecast

How is VVOS forecast to perform vs Medical Devices companies and vs the US market?
Company
127.52%
Industry
9.79%
Market
12.87%
VVOS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
VVOS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

VVOS vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
VVOS$2.46N/AN/A
HSCS$0.10N/AN/A
AIMD$1.04N/AN/A
THMO$0.68$5.00+635.29%Buy
OPGN$0.53N/AN/A

Vivos Therapeutics Stock Forecast FAQ

What is VVOS's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: VVOS) forecast ROE is -1,661.36%, which is considered weak.

If you're new to stock investing, here's how to buy Vivos Therapeutics stock.

What is VVOS's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: VVOS) forecast ROA is -63.64%, which is lower than the forecast US Medical Devices industry average of 10.67%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.